文献速递复苏、休克与脓毒症创伤与烧伤

抗凝血酶III通过防止Syndecan-1脱落和内皮屏障破坏介导新鲜冰冻血浆对失血性休克的保护作用

Antithrombin III Contributes to the Protective Effects of Fresh Frozen Plasma Following Hemorrhagic Shock by Preventing Syndecan-1 Shedding and Endothelial Barrier Disruption.
PubMed 文献 · Shock · 2020-01-01
一句话结论在失血性休克中,新鲜冰冻血浆保护内皮Syndecan-1和屏障功能的作用部分由抗凝血酶III介导,去除抗凝血酶III的血浆失去保护效应。

本研究探讨抗凝血酶III(ATIII)是否介导新鲜冰冻血浆(FFP)对失血性休克后内皮Syndecan-1(Sdc1)和通透性的保护作用。在125例严重创伤患者入院时和90例第3天检测ATIII与Sdc1,第3天两者呈显著负相关(R=-0.62,P<0.0001)。体外实验中,FFP和ATIII均防止TNFα诱导的人肺微血管内皮细胞通透性增加和Sdc1脱落,而ATIII缺陷FFP无效,回补ATIII后剂量依赖性恢复保护作用。小鼠失血性休克模型中,FFP复苏增加肺Sdc1表达(1.7±0.5 vs 休克组1.0±0.3,P<0.01),ATIII缺陷FFP无改善(1.3±0.4,P=0.3),回补ATIII后改善(1.5±0.9,P<0.05)。作者认为ATIII是减轻失血性休克内皮功能障碍的潜在治疗靶点,需进一步研究其保护机制。

要点

  • 严重创伤患者住院第3天血浆Sdc1与ATIII水平呈显著负相关(R=-0.62,P<0.0001,N=90)。
  • 体外实验中FFP和ATIII均防止TNFα诱导的人肺微血管内皮细胞通透性增加(P<0.05 vs TNFα),ATIII缺陷FFP无效,回补ATIII剂量依赖性恢复保护。
  • 小鼠失血性休克后FFP复苏增加肺Sdc1表达(1.7±0.5 vs 休克组1.0±0.3,P<0.01),ATIII缺陷FFP无改善(1.3±0.4,P=0.3)。
  • ATIII缺陷FFP回补ATIII后Sdc1表达改善(1.5±0.9,P<0.05),与FFP复苏效果相似。
  • 作者认为ATIII是FFP内皮保护作用的关键介质,为失血性休克内皮功能障碍的潜在治疗靶点。

适用人群与场景

  • 严重创伤患者入院时(N=125)及住院第3天(N=90)用于ATIII与Sdc1相关性分析。
  • 体外实验用人肺微血管内皮细胞(HLMVECs)。
  • 体内实验用雄性小鼠固定压力放血失血性休克模型。

处置流程与药物剂量

  • 体外实验:HLMVECs分别用溶剂、FFP、ATIII缺陷FFP或纯化ATIII预处理后给予TNFα刺激,检测Sdc1表达和通透性。
  • 小鼠失血性休克后分别用FFP、ATIII缺陷FFP或ATIII缺陷FFP回补ATIII进行复苏,评估肺Sdc1表达。

研究设计与关键结果

  • 严重创伤患者住院第3天血浆Sdc1与ATIII水平呈显著负相关(Pearson R=-0.62,P<0.0001,N=90)。
  • 体外:FFP和ATIII均防止TNFα诱导的HLMVECs通透性增加(P<0.05 vs TNFα);ATIII缺陷FFP无效应,回补ATIII后剂量依赖性恢复保护作用。
  • 体外:FFP和ATIII均防止TNFα诱导的HLMVECs Sdc1脱落;ATIII缺陷FFP无此作用。
  • 小鼠:FFP复苏后肺Sdc1表达为1.7±0.5,高于休克 alone 的1.0±0.3(P<0.01);ATIII缺陷FFP组为1.3±0.4(P=0.3,无改善);回补ATIII组为1.5±0.9(P<0.05),与FFP复苏相似。

证据类型、等级与局限

  • 证据类型:临床相关性分析、体外细胞实验和动物实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为ATIII在FFP介导的内皮Sdc1表达和屏障功能保护中起作用,是减轻失血性休克内皮功能障碍的潜在治疗靶点。
  • 原文结论指出需进一步研究阐明ATIII保护内皮的机制。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Endothelial dysfunction during hemorrhagic shock (HS) is associated with loss of cell-associated syndecan-1 (Sdc1) and hyperpermeability. Fresh frozen plasma (FFP) preserves Sdc1 and reduces permeability following HS, although the key mediators remain unknown. Antithrombin III (ATIII) is a plasma protein with potent anti-inflammatory and endothelial protective activity. We hypothesized that the protective effects of FFP on endothelial Sdc1 and permeability are mediated, in part, through ATIII.

METHODS: ATIII and Sdc1 were measured in severely injured patients upon admission (N = 125) and hospital day 3 (N = 90) for correlation analysis. In vitro effects of ATIII on human lung microvascular endothelial cells (HLMVECs) were determined by pretreating cells with vehicle, FFP, ATIII-deficient FFP, or purified ATIII followed by TNFα stimulation. Sdc1 expression was measured by immunostaining and permeability by electrical impedance. To determine the role of ATIII in vivo, male mice were subjected to a fixed pressure exsanguination model of HS, followed by resuscitation with FFP, ATIII-deficient FFP, or ATIII-deficient FFP with ATIII repletion. Lung Sdc1 expression was assessed by immunostaining.

RESULTS: Pearson correlation analysis showed a significant negative correlation between plasma levels of Sdc1 and ATIII (R = -0.62; P < 0.0001) in injured patients on hospital day 3. Also, in vitro, FFP and ATIII prevented TNFα-induced permeability (P < 0.05 vs TNFα) in HLMVECs. ATIII-deficient FFP had no effect; however, ATIII restoration reestablished its protective effects in a dose-dependent manner. Similarly, FFP and ATIII prevented TNFα-induced Sdc1 shedding in HLMVECs; however, ATIII-deficient FFP did not. In mice, Sdc1 expression was increased following FFP resuscitation (1.7 ± 0.5, P < 0.01) vs. HS alone (1.0 ± 0.3); however, no improvement was seen following ATIII-deficient FFP treatment (1.3 ± 0.4, P = 0.3). ATIII restoration improved Sdc1 expression (1.5 ± 0.9, P < 0.05) similar to that of FFP resuscitation.

CONCLUSIONS: ATIII plays a role in FFP-mediated protection of endothelial Sdc1 expression and barrier function, making it a potential therapeutic target to mitigate HS-induced endothelial dysfunction. Further studies are needed to elucidate the mechanisms by which ATIII protects the endothelium.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Lopez E, Peng Z, Kozar RA, et al. Antithrombin III Contributes to the Protective Effects of Fresh Frozen Plasma Following Hemorrhagic Shock by Preventing Syndecan-1 Shedding and Endothelial Barrier Disruption. Shock. 2020. PMID: 31389906. doi:10.1097/SHK.0000000000001432

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。